Skip to content
Eva Galka, M.D.
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Locations

Surgery

90 Crittenden Boulevard
Rochester, NY 14642

Surgery Center at Sawgrass

180 Sawgrass Drive, Suite 100
Rochester, NY 14620

Surgical Oncology

90 Crittenden Boulevard
Rochester, NY 14642

Surgical Oncology

160 Sawgrass Drive, Suite 120
Rochester, NY 14620

About Me

Professional Background

The University of Rochester Medical Center is pleased to announce the addition of Eva Galka, M.D. as an Assistant Professor of Surgery. Dr. Galka earned two Bachelor of Science degrees, with highest honors, in Ceramic Engineering and Biomedical Engineering & Applied Sciences from Rutgers University ...
The University of Rochester Medical Center is pleased to announce the addition of Eva Galka, M.D. as an Assistant Professor of Surgery. Dr. Galka earned two Bachelor of Science degrees, with highest honors, in Ceramic Engineering and Biomedical Engineering & Applied Sciences from Rutgers University College of Engineering in New Brunswick, New Jersey. She received her medical degree from Dartmouth Medical School in Hanover, New Hampshire.
From 2000 through 2007, Dr. Galka completed her internship and residency in general surgery, as well as a two-year fellowship in surgical research, at Pennsylvania State University/Hershey Medical Center in Pennsylvania. Dr. Galka completed a Surgical Oncology Fellowship at the University of Chicago in Illinois. She is licensed to practice medicine in the states of New York and Illinois and is board certified by the American Board of Surgery.
Dr. Galka has been the recipient of numerous awards and grants including the John Waldhausen Fellowship Award for Research, the American Physiological Society Research Recognition Award for Outstanding Abstract Presentation, the American Society of Colon and Rectal Surgeons (ASCRS) Research Grant and the University of Chicago Breast Cancer SPORE Developmental Research Project Grant. She has authored a wide variety of publications and has given numerous presentations at national surgery meetings throughout the United States.
In addition to being a member of professional organizations including the Society of Surgical Oncology, American Society of Clinical Oncology, American College of Surgeons, Association of Academic Surgeons and American Association of Cancer Research, Dr. Galka has developed clinical trials such as "A Pilot Study of Chemoprevention of Green Tea (Polyphenon E) in Women with Ductal Carcinoma in Situ (DCIS)."
Dr. Galka's clinical interests include the management of hepato-pancreatico-biliary (pancreatic and hepatobiliary cancers) and gastrointestinal malignancies, melanoma and sarcoma. Her research interests include understanding the mechanisms of apoptosis (programmed cell death) and its relation to novel treatments for cancer.

Certified Specialties

Preventive Medicine - American Board of Preventive Medicine

Faculty Appointments

Associate Professor - Department of Surgery, Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Surgical Oncology, University of Chicago Hospitals. 2007 - 2010

Residency, Surgery (General Surgery), Penn State Milton S Hershey Medical Center. 2001 - 2007

Internship, Surgery (General Surgery), Penn State Milton S Hershey Medical Center. 2000 - 2001

Graduate, Rutgers-The State University Of New Jersey School Of Engineering. 1994 - 1995

Graduate, Rutgers-The State University Of New Jersey School Of Engineering. 1990 - 1994

Education

MD | Dartmouth Medical School. 2000

Awards

John Waldhausen Fellowship Award for Research. 2004

American Physiological Society Research Recognition Award for Outstanding Abstract Presentation. 2004

Pennsylvania Society of Colon and Rectal Surgeons Research Presentation Award. 2004

Research

Clinical Trials

Melanoma Margins Trial-II - A Phase III, Multi-centre Randomised Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (02.18 MelMarT-II)

Lead Researcher: Eva Galka

Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus ...

Publications

Journal Articles

Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resection.

Burchard PR, Dave YA, Loria AP, Parikh NB, Pineda-Solis K, Ruffolo LI, Strawderman M, Schoeniger LO, Galka E, Tomiyama K, Orloff MS, Carpizo DR, Linehan DC, Hernandez-Alejandro R

HPB : the official journal of the International Hepato Pancreato Biliary Association.. 2022 January 25 Epub 01/25/2022.

Herpetic Whitlow-A Case of Inadvertent Inoculation With Melanoma Viral Therapy.

Mercurio MG, Galka E, Soh JM

JAMA dermatology.. 2018 December 1154 (12):1487-1488. Epub 1900 01 01.

Lingering Questions on Choledochal Cysts.

Linehan D, Galka E

JAMA surgery.. 2015 June 150 (6):584. Epub 1900 01 01.

The influence of staple size on fistula formation following distal pancreatectomy.

Sepesi B, Moalem J, Galka E, Salzman P, Schoeniger LO

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.. 2012 February 16 (2):267-74. Epub 10/21/2011.

Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?

Galka, E., Bickenbach, K., Roggin, K.K.

Surgical Oncology Clinics of NA. 2009; 18(2): 215-224.

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy

Mauceri, H.J., Beckett, M.A., Liang, H., Sutton, H.G., Pitroda, S., Galka, E., Efimova, E., Darga, T., Khodarev, N.N., King, C.R., Posner, M.C., Hellman, S., Kufe, D.W., Weichselbaum, R.R.

Cancer Gene Therapeutics. 2009; 16(4): 373-381.

Tubulovillous adenoma with atypia found at gastrojejunal anastomosis 8 years after gastric bypass for morbid obesity

Rogers, A.M., Capen, J., Galka, E., Cooney, R.N.

Surgery of Obestiy Related Diseases. 2007; 3(5): 559-560.

Stat6 (null phenotype) human lymphocytes exhibit increased apoptosis

Galka, E., Thompson, J.L., Zhang, W.J., Portiz, L.S., Koltun, W.A.

Journal of Surgical Research. 2004; 122(1): 14-20.

Human B lymphoblast cell lines defective of Stat6 signaling produce high levels of proinflammatroy cytokines IL-12, TNF-a and IFN-y.

Zhang, W.J., Koltun, W.A., Thompson, J.L., Tilberg, A.F., Galka, E., Portiz, L.S., Chorney, M.J.

Internal Journal of Oncology. 2004; 24(2): 447-53.

Disseminated intravascular coagulation as a complication of intrauterine balloon tamponade for post-hysteroscopic acute uterine bleeding

Galka, E., Goldfarb, H.

Journal of the American Association of Gynecologic Laparoscopists. 2004; 7(4): 573-6.

Increased apoptosis in Stat6 deficient cell lines may be due to interactions between Stat6 and NF-kB

Glaka, E., Thompson, J.L., Portiz, L.S., Fitzpatrick, L., Zhang, W.J., Koltun, W.A.

Gastroenterology. 2004; 126(4): A-139.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.